Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tele-homecare Service for Diabetic Foot Patients (Risk 0, Risk 1 and Risk 2 Level): Testing and Validation of Dedicated APPs and Artificial Intelligence Solutions

NCT05829811 is registered in ClinicalTrials.gov with Faculty Hospital AGEL Skalica as lead sponsor.

NCT NCT05829811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05829811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tele-homecare Service for Diabetic Foot Patients (Risk 0, Risk 1 and Risk 2 Level): Testing and Validation of Dedicated APPs and Artificial Intelligence Solutions
Lead sponsor
Faculty Hospital AGEL Skalica
Phase
Observational
Overall status
Not yet recruiting
Start date
September 1, 2023
Completion date
September 1, 2026
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

app elaborates data input from the patient with foot ulcer